BIRC5 and neoplasm: Targeting Survivin by using antisense nucleotides, dominant-negative mutants, ribozymes, or RNA interference (RNAi) results in spontaneous caspase-dependent cell death17 and tumor sensitization to chemotherapeutic agents, such as paclitaxel18, docetaxel19 and cisplatin20.